Cargando…

The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia

Background and Objective: Iron is an essential element that is necessary for all cells in the body. Iron deficiency anemia (IDA) is one of the most common nutritional disorders in both developed and developing countries. The glutathione pathway is paramount to antioxidant defense and glucose-6-phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozcicek, Fatih, Aktas, Mehmet, Türkmen, Kultigin, Coban, T Abdulkadir, Cankaya, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121703/
https://www.ncbi.nlm.nih.gov/pubmed/25097522
_version_ 1782329264333389824
author Ozcicek, Fatih
Aktas, Mehmet
Türkmen, Kultigin
Coban, T Abdulkadir
Cankaya, Murat
author_facet Ozcicek, Fatih
Aktas, Mehmet
Türkmen, Kultigin
Coban, T Abdulkadir
Cankaya, Murat
author_sort Ozcicek, Fatih
collection PubMed
description Background and Objective: Iron is an essential element that is necessary for all cells in the body. Iron deficiency anemia (IDA) is one of the most common nutritional disorders in both developed and developing countries. The glutathione pathway is paramount to antioxidant defense and glucose-6-phosphate dehydrogenase (G6PD)-deficient cells do not cope well with oxidative damage. The goal of this study was to check the activities of G6PD, 6-phosphogluconate dehydrogenase, glutathione reductase in patients with IDA. Methods: We analyzed the plasma samples of 102 premenopausal women with IDA and 88 healthy control subjects. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity as compared to the reduction of NADP +, glutathione reductase activity was performed based on the oxidation of NADPH. 2 ml of plasma were used in all analyzes. SPSS program was used for all of the statistical analysis. Result: Diagnosis of iron deficiency in patients belonging to the analysis of blood were ferritin 3.60 ± 2.7 ng / mL, hemoglobin 9.4 ± 1.5 mg / dl and hematocrit 30.7 ± 4.1% ratio; in healthy subjects ferritin 53.5 ± 41.7 ng/ml, hemoglobin level 13.9 ± 1.3 mg / dl and hematocrit ratio 42 ± 3.53%. When compared to healthy subjects the glutathione reductase level (P<0.001) was found to be significantly higher in patients with IDA. IDA patients with moderate and severe anemia had lower GR activity when compared to IDA patients with mild anemia. But the plasma levels of glucose-6-phosphate dehydrogenase (P<0,600) and 6-phosphogluconate dehydrogenase (P<0,671) did not show any differences between healthy subjects and in patients with IDA. Conclusion: It was shown that Glucose-6-Phosphate Dehydrogenase and 6-Phosphogluconate Dehydrogenase have no effect on iron-deficiency anemia in patients. The plasma GR levels of premenopausal women with IDA were found to be higher compared to healthy subjects, which could be secondary to erythrocyte protection against oxidative stress being commonly seen in IDA.
format Online
Article
Text
id pubmed-4121703
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Professional Medical Publicaitons
record_format MEDLINE/PubMed
spelling pubmed-41217032014-08-05 The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia Ozcicek, Fatih Aktas, Mehmet Türkmen, Kultigin Coban, T Abdulkadir Cankaya, Murat Pak J Med Sci Original Article Background and Objective: Iron is an essential element that is necessary for all cells in the body. Iron deficiency anemia (IDA) is one of the most common nutritional disorders in both developed and developing countries. The glutathione pathway is paramount to antioxidant defense and glucose-6-phosphate dehydrogenase (G6PD)-deficient cells do not cope well with oxidative damage. The goal of this study was to check the activities of G6PD, 6-phosphogluconate dehydrogenase, glutathione reductase in patients with IDA. Methods: We analyzed the plasma samples of 102 premenopausal women with IDA and 88 healthy control subjects. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity as compared to the reduction of NADP +, glutathione reductase activity was performed based on the oxidation of NADPH. 2 ml of plasma were used in all analyzes. SPSS program was used for all of the statistical analysis. Result: Diagnosis of iron deficiency in patients belonging to the analysis of blood were ferritin 3.60 ± 2.7 ng / mL, hemoglobin 9.4 ± 1.5 mg / dl and hematocrit 30.7 ± 4.1% ratio; in healthy subjects ferritin 53.5 ± 41.7 ng/ml, hemoglobin level 13.9 ± 1.3 mg / dl and hematocrit ratio 42 ± 3.53%. When compared to healthy subjects the glutathione reductase level (P<0.001) was found to be significantly higher in patients with IDA. IDA patients with moderate and severe anemia had lower GR activity when compared to IDA patients with mild anemia. But the plasma levels of glucose-6-phosphate dehydrogenase (P<0,600) and 6-phosphogluconate dehydrogenase (P<0,671) did not show any differences between healthy subjects and in patients with IDA. Conclusion: It was shown that Glucose-6-Phosphate Dehydrogenase and 6-Phosphogluconate Dehydrogenase have no effect on iron-deficiency anemia in patients. The plasma GR levels of premenopausal women with IDA were found to be higher compared to healthy subjects, which could be secondary to erythrocyte protection against oxidative stress being commonly seen in IDA. Professional Medical Publicaitons 2014 /pmc/articles/PMC4121703/ /pubmed/25097522 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ozcicek, Fatih
Aktas, Mehmet
Türkmen, Kultigin
Coban, T Abdulkadir
Cankaya, Murat
The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title_full The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title_fullStr The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title_full_unstemmed The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title_short The Investigation of Plasma Glucose-6-Phosphate Dehydrogenase, 6-Phoshogluconate Dehydrogenase, Glutathione Reductase in Premenauposal Patients with Iron Deficiency Anemia
title_sort investigation of plasma glucose-6-phosphate dehydrogenase, 6-phoshogluconate dehydrogenase, glutathione reductase in premenauposal patients with iron deficiency anemia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121703/
https://www.ncbi.nlm.nih.gov/pubmed/25097522
work_keys_str_mv AT ozcicekfatih theinvestigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT aktasmehmet theinvestigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT turkmenkultigin theinvestigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT cobantabdulkadir theinvestigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT cankayamurat theinvestigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT ozcicekfatih investigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT aktasmehmet investigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT turkmenkultigin investigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT cobantabdulkadir investigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia
AT cankayamurat investigationofplasmaglucose6phosphatedehydrogenase6phoshogluconatedehydrogenaseglutathionereductaseinpremenauposalpatientswithirondeficiencyanemia